These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17505515)

  • 41. Cytomegalovirus-infected neuroblastoma cells exhibit augmented invasiveness mediated by beta1alpha5 integrin (VLA-5).
    Scholz M; Blaheta RA; Wittig B; Cinatl J; Vogel JU; Doerr HW; Cinatl J
    Tissue Antigens; 2000 May; 55(5):412-21. PubMed ID: 10885561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells.
    Onafuye H; Pieper S; Mulac D; Cinatl J; Wass MN; Langer K; Michaelis M
    Beilstein J Nanotechnol; 2019; 10():1707-1715. PubMed ID: 31501742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of drug-resistant human neuroblastoma cells with cyclodextrin inclusion complexes of aphidicolin.
    Michaelis M; Cinatl J; Vogel JU; Pouckova P; Driever PH; Cinatl J
    Anticancer Drugs; 2001 Jun; 12(5):467-73. PubMed ID: 11395575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells.
    Groh T; Hrabeta J; Khalil MA; Doktorova H; Eckschlager T; Stiborova M
    Int J Oncol; 2015 Jul; 47(1):343-52. PubMed ID: 25963435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells.
    Michaelis M; Cinatl J; Anand P; Rothweiler F; Kotchetkov R; von Deimling A; Doerr HW; Shogen K; Cinatl J
    Cancer Lett; 2007 May; 250(1):107-16. PubMed ID: 17084521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthetic lethal hubs associated with vincristine resistant neuroblastoma.
    Fechete R; Barth S; Olender T; Munteanu A; Bernthaler A; Inger A; Perco P; Lukas A; Lancet D; Cinatl J; Michaelis M; Mayer B
    Mol Biosyst; 2011 Jan; 7(1):200-14. PubMed ID: 21031175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations in the glycoform of cisplatin-resistant human carcinoma cells are caused by defects in the endoplasmic reticulum-associated degradation system.
    Nakagawa H; Ohira M; Hayashi S; Abe S; Saito S; Nagahori N; Monde K; Shinohara Y; Fujitani N; Kondo H; Akiyama S; Nakagawara A; Nishimura S
    Cancer Lett; 2008 Nov; 270(2):295-301. PubMed ID: 18573595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
    Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
    Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of P-glycoprotein in L1210/VCR cells is associated with changes in several endoplasmic reticulum proteins that may be partially responsible for the lack of thapsigargin sensitivity.
    Seres M; Poláková E; Krizanová O; Hudecová S; Klymenko SV; Breier A; Sulová Z
    Gen Physiol Biophys; 2008 Sep; 27(3):211-21. PubMed ID: 18981537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.
    Liu LZ; Zhou XD; Qian G; Shi X; Fang J; Jiang BH
    Cancer Res; 2007 Jul; 67(13):6325-32. PubMed ID: 17616691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
    Zhang JH; Li AM; Chen S; Tong HX; Zhang KR; Zhang JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):47-50. PubMed ID: 18289471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents.
    Michaelis M; Rothweiler F; Agha B; Barth S; Voges Y; Löschmann N; von Deimling A; Breitling R; Doerr HW; Rödel F; Speidel D; Cinatl J
    Cell Death Dis; 2012 Apr; 3(4):e294. PubMed ID: 22476102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid.
    Jones J; Bentas W; Blaheta RA; Makarevic J; Hudak L; Wedel S; Probst M; Jonas D; Juengel E
    Int J Mol Med; 2008 Sep; 22(3):293-9. PubMed ID: 18698487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status.
    Winter C; Pawel B; Seiser E; Zhao H; Raabe E; Wang Q; Judkins AR; Attiyeh E; Maris JM
    Pediatr Blood Cancer; 2008 Jul; 51(1):10-6. PubMed ID: 18213713
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Establishment of an in vitro model for cisplatin resistance in human neuroblastoma cell lines.
    Ireland CM; Pittman SM; Jones SL; Harnett PR
    Anticancer Res; 1994; 14(6B):2397-403. PubMed ID: 7872659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells.
    Michaelis M; Rothweiler F; Barth S; Cinatl J; van Rikxoort M; Löschmann N; Voges Y; Breitling R; von Deimling A; Rödel F; Weber K; Fehse B; Mack E; Stiewe T; Doerr HW; Speidel D; Cinatl J
    Cell Death Dis; 2011 Dec; 2(12):e243. PubMed ID: 22170099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms of ellipticine-mediated resistance in UKF-NB-4 neuroblastoma cells.
    Procházka P; Libra A; Zemanová Z; Hřebačková J; Poljaková J; Hraběta J; Bunček M; Stiborová M; Eckschlager T
    Cancer Sci; 2012 Feb; 103(2):334-41. PubMed ID: 22040216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mycophenolate mofetil increases adhesion capacity of tumor cells in vitro.
    Blaheta RA; Bogossian H; Beecken WD; Jonas D; Hasenberg C; Makarevic J; Ogbomo H; Bechstein WO; Oppermann E; Leckel K; Cinatl J
    Transplantation; 2003 Dec; 76(12):1735-41. PubMed ID: 14688525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [MDR-reversing effect of short peptide binding specifically to multidrug-resistant gastric cancer cells].
    Wang P; Ding J; Lin T; Han S; Cao SS; Ge FL; An GQ; Li R; Lei T; Bai FH; Fan DM
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):258-61. PubMed ID: 17760250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.